Higher proportions of CD39+ tumor-resident cytotoxic T cells predict recurrence-free survival in patients with stage III melanoma treated with adjuvant immunotherapy

• Andrew J Colebatch,
• John F Thompson,
• Serigne Lo,
• Ines Pires da Silva,
• Georgina V Long,
• Richard A Scolyer,
• Kazi J Nahar,
• Tasnia Ahmed,
• Umaimainthan Palendira,
• Alexander M Menzies,
• Jordan W Conway,
• Matteo S Carlino,
• Ismael A Vergara,
• James S Wilmott,
• Grace Heloise Attrill,
• Carina N Owen

Affiliations

Andrew J Colebatch

1 Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia

John F Thompson

Melanoma Institute Australia, Sydney, New South Wales, Australia

Serigne Lo

Melanoma Institute Australia and University of Sydney, Sydney, New South Wales, Australia

Ines Pires da Silva

Melanoma Institute Australia and University of Sydney, Sydney, New South Wales, Australia

Georgina V Long

Melanoma Institute Australia and University of Sydney, Sydney, New South Wales, Australia

Richard A Scolyer

Melanoma Institute Australia, North Sydney, New South Wales, Australia

Kazi J Nahar

Melanoma Institute Australia, North Sydney, New South Wales, Australia

Tasnia Ahmed

Melanoma Institute Australia, North Sydney, New South Wales, Australia

Umaimainthan Palendira

Central Clinical School, The University of Sydney, Sydney, New South Wales, Australia

Alexander M Menzies

Melanoma Institute Australia and University of Sydney, Sydney, New South Wales, Australia

Jordan W Conway

Melanoma Institute Australia, North Sydney, New South Wales, Australia

Matteo S Carlino

Melanoma Institute Australia and University of Sydney, Sydney, New South Wales, Australia

Ismael A Vergara

Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia

James S Wilmott

Melanoma Institute Australia, North Sydney, New South Wales, Australia

Grace Heloise Attrill

Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia

Carina N Owen

Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia